Page 410 - IJB-10-2
P. 410

International Journal of Bioprinting                            3D-bioprinted macrophage inflammation model




            from harvested cells using ISOLATE II RNA Mini Kit   6-diamidino-2-phenylindole; Sigma-Aldrich, Australia),
            (Meridian Life  Science, Australia)  and  quantified  using   and 0.8 U/mL TRITC-Ph (tetramethylrhodamine-
            Thermo Fisher Scientific NanoDrop ONE  (Australia).   conjugated phalloidin; Sigma-Aldrich, Australia) in PBS
                                                c
            Complementary DNA (cDNA) for the isolated RNA was   for 1 h at room temperature. The final constructs were
            prepared using SuperScript III First-Strand Synthesis kit   imaged  using  Nikon Eclipse  Ti confocal  microscope.
                                   ™
            (Invitrogen) in SimpliAmp  Thermal Cycler (Applied   Excitation/emission wavelengths used for the secondary
            Biosystems by Thermo Fisher Scientific, Australia). Real-  antibody (for iNOS in green color), DAPI (for nucleus
            time quantitative polymerase chain reaction (RT-qPCR)   in blue color), and TRITC-Ph (for actin filaments in red
            for M1 (IL-1β, IL-6, iNOS, and TNF-α) and M2a (CD206   color) were 488 nm/500–550 nm, 405 nm/417–477 nm,
            and DC-SIGN) markers was performed with StepOnePlus    and 561 nm/570–1000 nm, respectively.
                                                         ™
            Real-Time PCR System (Applied Biosystems) using SYBR
                                                         ®
            Green master mix (Invitrogen). The forward and reverse   2.8. Action of Ibu in the 3D-bioprinted
            primers used for the RT-qPCR are listed in Table S1   inflammation model
            (Supplementary File). The recorded cycle threshold (C )   THP-1 were 3D-bioprinted, differentiated to M0 (PMA,
                                                         t
            values were used to calculate the fold change using the   25 ng/mL for 2 days and resting for 1 day), and polarized
            Livak method (ΔΔCt method).  The fold change (2 −ΔΔCt )   to M1 (LPS, 1000 ng/mL for 2 days). The concentrations
                                     27
            is the relative gene expression (2 −ΔCt ) in the 3D-bioprinted   of 10 and 15 µg/mL Ibu (Sigma-Aldrich, Australia) were
                                                                                                         28
            constructs divided by the 2 −ΔCt  of the 2D-cultured M0.   selected for the study based on Ibu pharmacokinetics.  The
                                                               M1-polarized constructs were incubated with 10 µg/mL
            2.6. Optimization of LPS dose                      (Ibu1) and 15 µg/mL Ibu (Ibu2) in BM for 3 days, with M1-
            Activation of M1 macrophages within the 3D-bioprinted   polarized constructs without Ibu and M0-differentiated
            constructs in the presence of increasing doses of Ec-LPS   constructs as negative and positive control, respectively.
            was investigated. Bioprinted THP-1 were differentiated to   Test, negative control, and positive control constructs
            M0 using the optimized PMA dose of 25 ng/mL for 2 days.   (n = 3) were collected on days 1 and 3 for gene expression
            After 1 day of rest, the culture media (1 mL/construct) were   analysis (described in section 2.5). Relative gene expression
            replaced with BM in the presence of increasing doses of Ec-  was normalized to the relative gene expression of positive
            LPS (0, 50, 100, 200, 500, 1000, 5000, and 10,000 ng/mL;    control (M0) to calculate fold change. Phenotypic
            n = 3) and incubated for 3 days. The conditioned media were   characterization of M1 macrophages after 3 days of Ibu
            collected and replenished with fresh media and respective   treatment was performed via flow cytometry (n = 3) for
            Ec-LPS doses at 1, 2, and 3 days. The release of M1-specific   M0 markers (CD11b and CD33) and M1 marker (CD80).
            cytokine (IL-6) in the conditioned media was quantified   Conditioned media from each group were collected
            using ELISA (Thermo Fisher Scientific, Australia) as per   on days 1, 2, and 3 of culture, and ELISA was used to
            the manufacturer’s instructions and normalized to the wet   measure levels of secreted IL-6, IL-1β, TNF-α (Thermo
            weight of each construct measured at day 3. Cells retrieved   Fisher Scientific, Australia), and prostaglandin E2 (PGE ;
            from  collagenase-digested  constructs  were  assessed  for   Cayman Chemical, USA). The cumulative quantity of
                                                                                                            2
            expression of the M1-specific surface marker CD80 by flow   released protein was normalized with the wet weight of the
            cytometry (section 2.4).
                                                               constructs. The effect of Ibu on the polarized 3D-bioprinted
            2.7. iNOS expression                               M1 cells was also evaluated by measuring the secretion of
            The expression of iNOS in M1-polarized cells within   TNF-α and IL-1β using ELISA.
            3D bioprinted constructs was visualized using      2.9. Statistical analysis
            immunofluorescence. At day 3, non-polarized M0     All the data are presented as mean ± SD and were analyzed
            constructs and M1-polarized (using optimal Ec-LPS dose   using GraphPad Prism Version  8. One-way and two-
            1000 ng/mL) constructs were fixed in 4% (w/v) PFA for   way analyses of variance (ANOVA) with a Tukey post-
            20 min and permeabilized using 0.2% (v/v) Triton X-100   hoc analysis were used to test for differences between
            for 30 min. Afterward, the constructs were incubated in   experimental and control groups. Statistical significance
            blocking buffer (1% (w/v) bovine serum albumin and   was set at p ≤ 0.05.
            10% (v/v) normal goat serum in DPBS) for 2 h at room
            temperature, then 200 ng/µL of anti-iNOS primary   3. Results and discussion
            antibody (Abcam, UK) in blocking buffer for 24 h at
            4°C. Thereafter, the constructs were incubated with 5 ng/  3D bioprinting is an innovative additive manufacturing
            µL  secondary  antibody  Alexa  Fluor   488-conjugated-  technology that enables the construction of tissue-
                                           ®
            anti mouse antibody (Abcam, UK), 5 µg/mL DAPI (4’,   or organ-like structures through a layer-by-layer


            Volume 10 Issue 2 (2024)                       402                                doi: 10.36922/ijb.2116
   405   406   407   408   409   410   411   412   413   414   415